Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Prenatal Screening Subsidiary Moves to Larger Facility on Long Island

NEW YORK (GenomeWeb News) – PerkinElmer said on Tuesday that its prenatal screening subsidiary NTD Laboratories has relocated to a new 22,000-square-foot facility in Melville, NY.
 
PerkinElmer said that NTD moved to the new facility from its previous location in Huntington Station, NY, to meet increasing demand for prenatal screening, including tests for Down syndrome, trisomy 18/13, and open neural tube defects, among others.
 
The facility, which PerkinElmer said has been certified by the New York Department of Health, will serve as NTD’s new headquarters. It will use an IT system based on the company's Specimen Gate LIMS, and it will house a maternal sample bank.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.